CVS Health Corp
General ticker "CVS" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $67.4B
CVS Health Corp does not follow the US Stock Market performance with the rate: -31.8%.
Estimated limits based on current volatility of 1.9%: low 42.94$, high 44.61$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-10-21, amount 0.67$ (Y6.07%)
- Current price 31.5% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [64.46$, 96.78$]
- 2024-12-30 to 2025-12-30 estimated range: [75.18$, 110.65$]
Financial Metrics affecting the CVS estimates:
- Positive: Non-GAAP EPS, $ of 8.74 > 2.29
- Positive: Operating cash flow per share per price, % of 14.25 > 12.76
- Negative: Investing cash flow per share, $ of -16.26 <= -3.48
- Positive: 1.31 < Industry earnings per price (median), % of 1.35
- Positive: 1.03 < Operating profit margin, % of 3.84
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 3.24
Short-term CVS quotes
Long-term CVS plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $292,111.00MM | $316,664.00MM | $357,776.00MM |
Operating Expenses | $278,801.00MM | $308,710.00MM | $344,033.00MM |
Operating Income | $13,310.00MM | $7,954.00MM | $13,743.00MM |
Non-Operating Income | $-2,773.00MM | $-2,118.00MM | $-2,570.00MM |
Interest Expense | $2,503.00MM | $2,287.00MM | $2,658.00MM |
Income(Loss) | $10,537.00MM | $5,836.00MM | $11,173.00MM |
Taxes | $2,548.00MM | $1,509.00MM | $2,805.00MM |
Profit(Loss) | $7,989.00MM | $4,327.00MM | $8,368.00MM |
Stockholders Equity | $75,075.00MM | $71,469.00MM | $76,461.00MM |
Inventory | $17,760.00MM | $19,090.00MM | $18,025.00MM |
Assets | $232,999.00MM | $228,275.00MM | $249,728.00MM |
Operating Cash Flow | $18,265.00MM | $16,177.00MM | $13,426.00MM |
Capital expenditure | $2,520.00MM | $2,727.00MM | $3,031.00MM |
Investing Cash Flow | $-5,261.00MM | $-5,047.00MM | $-20,889.00MM |
Financing Cash Flow | $-11,356.00MM | $-10,516.00MM | $2,683.00MM |
Earnings Per Share* | $6.00 | $3.29 | $6.49 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.